Morimura Y, Nishiyama H, Hashimoto T, Fujimori K, Yamada H, Yanagida K, Sato A
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, Fukushima City, Japan.
Fukushima J Med Sci. 1999 Dec;45(2):109-16.
The Japanese Society of Gynecologist and Obstetrician (JSGO) revised criteria for early uterine cervical cancer.
In this study, we investigated the value of the revised JSGO criteria.
Retrospective review was performed for 70 patients with tumors limited to the uterine cervix who were classified stage I under old JSGO criteria.
Forty patients were re-classified into stage IA1 and 4 patients into stage IA2. Incidence of lymph-vascular infiltration (LVI) in stage IA1 and IA2 were 5% and 25%. There was one patient with stage IA1 disease who had nodal metastasis and no patients with stage IA2 disease. There were 14 patients with stage IB1 disease and 12 patients with stage IB2 disease. Mortality of patients with stage IB2 disease was 25% and significantly higher than that of patients with stage IA and IB1 disease (P<0.001 and <0.05)
Although the revised JSGO criteria for early cervical cancer are acceptable for assessment of patients, the therapy of patients is still controversial. We recommend that patients with stage IA1 and negative LVI should have less radical hysterectomy and patients with stage IA1 with LVI or stage IA2, IB should have radical hysterectomy.
日本妇产科医师协会(JSGO)修订了早期子宫颈癌的诊断标准。
在本研究中,我们调查了修订后的JSGO标准的价值。
对70例肿瘤局限于子宫颈且按照旧的JSGO标准被分类为I期的患者进行回顾性分析。
40例患者被重新分类为IA1期,4例患者被重新分类为IA2期。IA1期和IA2期的淋巴血管浸润(LVI)发生率分别为5%和25%。有1例IA1期疾病患者发生了淋巴结转移,而IA2期疾病患者无淋巴结转移。有14例患者为IB1期疾病,12例患者为IB2期疾病。IB2期疾病患者的死亡率为25%,显著高于IA期和IB1期疾病患者(P<0.001和<0.05)。
尽管修订后的JSGO早期宫颈癌标准可用于评估患者,但患者的治疗仍存在争议。我们建议IA1期且无LVI的患者应行不太根治性的子宫切除术,而IA1期有LVI或IA2期、IB期的患者应行根治性子宫切除术。